Undervalued Biotech Analysis

This page is an archive of all the due diligence on this website.

Antimicrobial
Spero Therapeutics (SPRO) 13 October 2025

CNS
Cognition Therapeutics (CGTX) 20 September 2025
CGTX Update (CGTX) 26 March 2026

Gene Editing/Cell Therapy
Solid Bioscience (SLDB) 26 October 2025
Artiva Biotherapeutics (ARTV) 15 May 2026

Hepatology/Metabolic
Aligos Therapeutics (ALGS) 6 October 2025
Inventiva S.A. (IVA) 16 October 2025
Zeland Pharma (ZEAL) 10 March 2026

Immunology
Moonlake Immunotherapeutics (MLTX) 7 November 2025
Moonlake Follow Up (MLTX) 31 March 2026

Oncology
IN8bio (INAB) 20 November 2025
IN8bio Update 18 February 2026
Janux Therapeutics (JANX) 2 December 2025


General Article
The Weight Loss World War Expands 9 December 2025
Weight Loss World War II 3 December 2025
Price Action per Clinical Stages 25 November 2025
Rare Genetic Disease 5 November 2025
ADR Stock Warning 29 October 2025
TCE (T-Cell Engagers) 11 March 2026
Guide to Lipoprotein(a) (LP(a)) 17 April 2026